BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28064072)

  • 1. Long-term outcome of breast cancer patients with pathologic N3a lymph node stage.
    Grassadonia A; Vici P; Gamucci T; Moscetti L; Pizzuti L; Mentuccia L; Iezzi L; Scognamiglio MT; Zilli M; Giampietro J; Graziano V; Natoli C; Tinari N
    Breast; 2017 Apr; 32():79-86. PubMed ID: 28064072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
    Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K
    Med Oncol; 2013; 30(3):615. PubMed ID: 23729267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNM classification and the need for revision of pN3a breast cancer.
    van Nijnatten TJA; Moossdorff M; de Munck L; Goorts B; Vane MLG; Keymeulen KBMI; Beets-Tan RGH; Lobbes MBI; Smidt ML
    Eur J Cancer; 2017 Jul; 79():23-30. PubMed ID: 28458119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
    Tan QX; Qin QH; Yang WP; Mo QG; Wei CY
    Int J Clin Exp Pathol; 2014; 7(10):6862-70. PubMed ID: 25400769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study.
    Li FY; Wu SG; Zhou J; Sun JY; Lin Q; Lin HX; Guan XX; He ZY
    PLoS One; 2014; 9(2):e87264. PubMed ID: 24498305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
    Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term survival of women with locally advanced breast cancer with ≥ 10 involved lymph nodes at diagnosis.
    Zeichner SB; Cavalcante L; Suciu GP; Ruiz AL; Hirzel A; Krill-Jackson E
    Asian Pac J Cancer Prev; 2014; 15(8):3435-41. PubMed ID: 24870735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the outcome of breast cancer patients with 10 or more metastasized axillary lymph nodes.
    Lee JS; Kim SI; Choi SY; Park HS; Lee JS; Park S; Koo J; Park BW; Lee KS
    Int J Clin Oncol; 2011 Oct; 16(5):473-81. PubMed ID: 21360123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
    Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
    Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
    Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
    Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
    Agresti R; Martelli G; Sandri M; Tagliabue E; Carcangiu ML; Maugeri I; Pellitteri C; Ferraris C; Capri G; Moliterni A; Bianchi G; Mariani G; Trecate G; Lozza L; Langer M; Rampa M; Gennaro M; Greco M; Menard S; Pierotti MA
    Cancer; 2014 Mar; 120(6):885-93. PubMed ID: 24323615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer.
    Cubukcu E; Kanat O; Fatih Olmez O; Kabul S; Canhoroz M; Avci N; Deligonul A; Hartavi M; Cubukcu S; Olmez F; Kurt E; Evrensel T; Gokgoz S; Manavoglu O
    J BUON; 2013; 18(2):359-65. PubMed ID: 23818346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
    Andersson Y; Bergkvist L; Frisell J; de Boniface J
    Breast Cancer Res Treat; 2018 Sep; 171(2):359-369. PubMed ID: 29846847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.